From Answers to Agents: What Must Change Before Generative and Agentic AI Become Clinical Infrastructure in Hematology
Generative artificial intelligence in hematology is entering a new phase. The dominant question, whether large language models are accurate enough for clinical decision support, is being overtaken by a harder one, as systems shift from answering questions to acting: extracting structured cases, routing them, classifying variants, and grounding recommendations in guidelines and case memory. In 2026, a hematology agent achieved roughly 83% concordance with tumor-board decisions in a prospective silent trial, with…
From Answers to Agents: What Must Change Before Generative and Agentic AI Become Clinical Infrastructure in Hematology: In 2026, a hematology agent achieved roughly 83% concordance with tumor-board decisions in a prospective silent trial, with hallucinations in 0.3%, suggesting that for well-structured tasks the binding constraint is shifting from accuracy to governability.
Evidence
- Peer-reviewedTurkish Journal of Hematology2026-09-21
How should this claim be treated?
Truvace Impact Record TRV-2026-1168, v1: “From Answers to Agents: What Must Change Before Generative and Agentic AI Become Clinical Infrastructure in Hematology.” Truvace, 2026-09-22. /record/TRV-2026-1168 (accessed at citation time). sha256 588383241407bfcb…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1168 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace